Medvantx is a premier administrator of Patient Assistance Fulfillment Programs (PAP Program)
Develop your Patient Assistance Program with flexible and scalable solutions for pharmaceutical manufacturers and device partners. Our experienced team of over 40+ pharmacists and industry-leading Patient Assistance Program compliance standards make us a trusted partner for top prescription manufacturers. Let us help you strategize and deliver scalable patient assistance program solutions for access to necessary medications. Leave the dispensing to us with our two major facilities, located in Sioux Falls, SD, and in Louisville, KY. Partner with Medvantx and make a meaningful difference in patients’ lives today!
Learn more about Partnering with Medvantx in Patient Assistance Programs.
How Manufacturers Can Get Started with Our Patient Assistance Program
Discover Medvantx’s Patient Assistance Program (PAP), your gateway to essential medication support for patients. Partnered with 5 of the 10 largest pharmaceutical manufacturers nationwide, Medvantx offers comprehensive assistance programs designed to help patients access the medications they need at an affordable cost. Whether they are facing financial challenges or require help navigating the complexities of medication access, our PAP program connects patients with vital resources and pharmacy support.
Learn more about how you can partner with Medvantx’s extensive network, assisting patients in obtaining necessary medications and improving health outcomes.
Learn More About Patient Assistance Program Partnerships
The Importance of Patient Assistance Programs
Despite efforts to make healthcare more accessible, there are still people who are uninsured or underinsured in the United States. Patient Assistance Programs (PAPs) help bridge the gap, allowing individuals who lack requisite health insurance to receive the necessary prescriptions they need.
Generally, the process to receive medications through Patient Assistance Programs requires the following steps:
- The patient is made aware of PAPs by their healthcare provider or by searching the manufacturer’s website.
- The patient applies for a PAP and submits eligibility paperwork, which may include income eligibility or insurance documents.
- Once approved, the patient will provide a valid prescription to the participating pharmacy, like Medvantx, and receive their medication.
Our unique platform, Medvantx INSIGHTS, improves prescription support services, enhances patient care assistance and provides a seamless medication assistance program. This platform is equipped with tools for patient access, cash pay, and other clinical applications, delivering an array of solutions accessible via cloud and mobile platforms.
Schedule a Demo for our Patient Assistance Program
For Patients
A Patient Assistance Program is a support option created by pharmaceutical manufacturers to help patients who cannot afford their medications. These programs make treatment accessible by providing medicines at little or no cost for eligible patients.
Most PAP Programs are designed for patients who are uninsured, underinsured, or facing financial hardship. Qualification often depends on income level, insurance status, and a valid prescription from a licensed healthcare provider.
Once approved, the PAP Program supplies the prescribed medication directly to the patient or their healthcare provider. This ensures patients can start or continue therapy without treatment delays caused by insurance or financial barriers.
In most cases, the medication is provided at no cost to the patient. However, patients may still need to cover routine medical visits, lab tests, or other non-covered healthcare expenses.
Enrolment duration varies by program. Some last for a few months, while others require annual renewal. Patients are usually asked to re-submit financial and prescription information to confirm eligibility for continued support.
For Manufacturers
Patient Assistance Programs help manufacturers improve therapy adoption and adherence by removing financial barriers. They also demonstrate a commitment to patient care, strengthening trust between healthcare providers, patients, and the brand.
By ensuring patients can access therapy from the beginning, PAP Programs help prevent treatment gaps. This builds loyalty, reduces the chance of patients switching to alternatives, and supports stronger long-term outcomes for both patients and manufacturers.
Manufacturers must follow strict industry regulations when running a PAP Program. This includes transparent eligibility criteria, fair distribution practices, and robust reporting processes to maintain compliance with federal and state laws.
Yes. PAP Programs can be tailored based on the type of medication, patient population, and manufacturer’s goals. For example, specialty drugs, chronic disease treatments, or rare disease therapies may have unique PAP structures.
Program success is often tracked by monitoring patient access rates, adherence levels, renewal applications, and overall program satisfaction. These insights help manufacturers refine their support model and demonstrate measurable value.
